Verastem is a pharmaceutical company that specializes in developing drugs for cancer treatment. They are developing several products, including VS-6766 and RAMP 201 and 202, which are all in clinical trials for cancer treatment. In addition, they have licensing agreements with Chugai Pharmaceutical and Pfizer Inc. and a clinical collaboration agreement with Amgen, Inc.